『大東世語』「紕漏」篇注釈稿

departmental bulletin pape

Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences-3

<p><b>Copyright information:</b></p><p>Taken from "Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences"</p><p>http://www.biomedcentral.com/1471-2350/8/78</p><p>BMC Medical Genetics 2007;8():78-78.</p><p>Published online 11 Dec 2007</p><p>PMCID:PMC2222244.</p><p></p>es. , (subject IX-23); , (IX-20); , (VIII-24); , (IV-7); , (III-3); , (V-6); , (V-3). Phenotypic categories are given in Figure 3

Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences-0

<p><b>Copyright information:</b></p><p>Taken from "Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences"</p><p>http://www.biomedcentral.com/1471-2350/8/78</p><p>BMC Medical Genetics 2007;8():78-78.</p><p>Published online 11 Dec 2007</p><p>PMCID:PMC2222244.</p><p></p>es. , (subject IX-23); , (IX-20); , (VIII-24); , (IV-7); , (III-3); , (V-6); , (V-3). Phenotypic categories are given in Figure 3

Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences-4

<p><b>Copyright information:</b></p><p>Taken from "Synpolydactyly and HOXD13 polyalanine repeat: addition of 2 alanine residues is without clinical consequences"</p><p>http://www.biomedcentral.com/1471-2350/8/78</p><p>BMC Medical Genetics 2007;8():78-78.</p><p>Published online 11 Dec 2007</p><p>PMCID:PMC2222244.</p><p></p>clinical categories (A, B, C, D), drawn according to the scheme described by Malik et al. [8]. Genotypes for the GCN-region of are also provided (see Figures 1; 4)